Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0JDM stock hub

LON/0JDM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0JDMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0JDM

In the news

Latest news · LON/0JDM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 12.9P50 16.9P75 23.5

Trailing P/E20.9

P25 15.9P50 22.9P75 35.8

ROE22.5

P25 -54.2P50 2.1P75 13.7

ROIC9.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0JDM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	93,000
Employees Change	5,000%
Employees Change Percent	5.68
Enterprise value	$32.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US46266C1053
Last refreshed	2026-05-10
Market cap	$21.9B
Price	$178
Price currency	USD
Rev Per Employee	135,435.45x
Sector	Healthcare
Sic	8731
Symbol	lon/0JDM
Website	https://www.iqvia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.79%
EV Earnings	30.83x
EV/EBIT	18.52x
EV/EBITDA	13.76x
EV/FCF	20.18x
EV/Sales	2.65x
FCF yield	7.32%
Forward P/E	13.47x
P/B ratio	4.55x
P/E ratio	20.87x
P/S ratio	1.74x
PE Ratio10 Y	76.5x
PE Ratio3 Y	28.21x
PE Ratio5 Y	35.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.06%
EBITDA Margin	18.04%
FCF margin	12.72%
Gross margin	32.99%
Gross Profit	$4.2B
Gross Profit Growth	1.99%
Gross Profit Growth Q	4.39%
Gross Profit Growth3 Y	2.89%
Gross Profit Growth5 Y	6.29%
Net Income	$1B
Net Income Growth	3.82%
Net Income Growth Q	10.04%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	9.5%
Net Income Growth5 Y	27.63%
Pretax Margin	9.84%
Profit Margin	8.33%
Profit Per Employee	$11,278
Profitable Years	14
ROA	5.13
Roa5y	4.73
ROCE	10.95
ROE	22.49
Roe5y	20.22
ROIC	9.6
Roic5y	9.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	17.71%
Cagr3y	-1.38%
Cagr5y	-5.16%
EPS Growth	9.9
EPS Growth Q	15
EPS Growth Quarters	3
EPS Growth Years	6
EPS Growth3 Y	13.21
EPS Growth5 Y	30.9
FCF Growth	-2.17%
FCF Growth Q	15.26%
FCF Growth3 Y	11.95%
FCF Growth5 Y	0.74%
OCF Growth	-2.1%
OCF Growth Q	8.8%
OCF Growth10 Y	15.28%
OCF Growth3 Y	7.63%
OCF Growth5 Y	0.31%
Revenue Growth	7.32x
Revenue Growth Q	8.41x
Revenue Growth Quarters	23x
Revenue Growth Years	13x
Revenue Growth3 Y	4.69x
Revenue Growth5 Y	6.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.58
Assets	$22.5B
Cash	$1.6B
Current Assets	$4.6B
Current Liabilities	$6.1B
Debt	$12.3B
Debt EBITDA	$5.13
Debt Equity	$2.55
Debt FCF	$7.66
Equity	$4.8B
Interest Coverage	3.09
Liabilities	$17.7B
Long Term Assets	$17.9B
Long Term Liabilities	$11.6B
Net Cash	$-10.7B
Net Cash By Market Cap	$-48.83
Net Debt EBITDA	$4.7
Net Debt Equity	$2.22
Net Debt FCF	$6.67
Tangible Book Value	$-11.5B
Tangible Book Value Per Share	$-68.63
WACC	8.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.75
Net Working Capital	$-1.7B
Quick ratio	0.66
Working Capital	$-1.6B
Working Capital Turnover	$-7.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	17.7%
200-day SMA	197
3Y total return	-4.1%
50-day SMA	170.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-23.27%
All Time High	284.7
All Time High Change	-37.36%
All Time High Date	2021-12-30
All Time Low	90.23
All Time Low Change	97.67%
All Time Low Date	2020-03-24
ATR	8.58
Beta	1.18
Ch YTD	-21.19
High	186.6
High52	246.8
High52 Date	2026-01-09
High52ch	-27.74%
Low	175.8
Low52	134.8
Low52 Date	2025-05-23
Low52ch	32.27%
Ma50ch	4.85%
Price vs 200-day SMA	-9.47%
RSI	59.7
RSI Monthly	45.86
RSI Weekly	47.14
Sharpe ratio	0.47x
Sortino ratio	0.87
Total Return	5.55%
Tr YTD	-21.19
Tr1m	5.52%
Tr1w	13.13%
Tr3m	-5.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.8B
Operating Income Growth	2.41
Operating Income Growth Q	7.62
Operating Income Growth3 Y	8.19
Operating Income Growth5 Y	19.64
Operating margin	14.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	158,532,032%
Net Borrowing	916,892,500
Shares Insiders	0.97%
Shares Institutions	100.06%
Shares Qo Q	-1.22%
Shares Yo Y	-5.55%
Short Ratio	2.33

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.4B
Average Volume	907.05x
Bv Per Share	28.23
CAPEX	$-445.3M
Ch1m	5.52
Ch1w	13.13
Ch1y	17.7
Ch3m	-5.58
Ch3y	-4.1
Ch5y	-23.27
Ch6m	-14.92
Change	-0.57%
Change From Open	-3.28
Close	179.4
Days Gap	2.8
Depreciation Amortization	486,319,782
Dollar Volume	63,669.2
Earnings Date	2026-05-05
EBIT	$1.8B
EBITDA	$2.3B
EPS	$6.11
F Score	5
FCF	$1.6B
FCF EV Yield	4.95x
Financing CF	-246,124,125
Fiscal Year End	December
Goodwill	12,135,255,616
Graham Number	86.79013
Graham Upside	-51.34
Income Tax	$189.3M
Investing CF	-1,663,041,780
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	$214
Lynch Upside	19.79
Ma150	200.2
Ma150ch	-10.93%
Ma20	169.7
Ma20ch	5.08%
Net CF	156,762,135
Open	184.4
P FCF Ratio	13.66
P OCF Ratio	10.69
Position In Range	23.67
Ppne	593,412,826
Price Date	2026-05-08
Price EBITDA	$9.63
Relative Volume	0.4x
Revenue	12,595,496,760x
SBC By Revenue	1.44x
Share Based Comp	181,753,200
Tax By Revenue	1.5x
Tax Rate	15.27%
Tr6m	-14.92%
Volume	357
Z Score	1.92

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0JDM pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0JDM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0JDM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+100.1%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0JDM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.7

Neutral momentum band

Price vs 200-day MA

-9.5%

50/200-day relationship not available

Beta (5Y)

1.18

Moves roughly with the market

Sharpe ratio

0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0JDM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0JDM stock rating?

lon/0JDM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0JDM analysis?

The full report lives at /stocks/lon/0JDM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0JDM?

The latest report frames lon/0JDM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0JDM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.